Transdermal films containing tizanidine: in vitro and in vivo evaluation

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Drug Delivery Science and Technology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/S1773-2247(14)50013-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• FORMULATION AND EVALUATION OF TIZANIDINE HYDROCHLORIDE TRANSDERMAL PATCHES

  2014cited by this paper
• DEVELOPMENT OF TRANSDERMAL DRUG DELIVERY SYSTEM OF A MODEL ANTIDIABETIC AGENT

  2011cited by this paper
• Spectrophotometric determination of tizanidine and orphenadrine via ion pair complex formation using eosin Y

  2011cited by this paper
• DEVELOPMENT AND CHARACTERIZATION OF TRANSDERMAL PATCHES OF METOPROLOL TARTRATE

  2010cited by this paper
• A Validated Reversed Phase HPLC-Method for the Determination of Aceclofenac and Tizanidine in Tablets

  2010cited by this paper
• A combined approach of chemical enhancers and sonophoresis for the transdermal delivery of tizanidine hydrochloride

  2009cited by this paper
• Formulation and Evaluation of Bioadhesive Buccal Drug Delivery of Tizanidine Hydrochloride Tablets

  2009cited by this paper
• Analysis of skin disposition and metabolism of ethyl nicotinate after topical application using dual agar gel disc-inserted rats.

  2008cited by this paper
• Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.

  2007cited by this paper
• Development and evaluation of carvedilol transdermal patches

  2007cited by this paper
• Transdermal therapeutic system of carvedilol: Effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics

  2007cited by this paper
• Dose translation from animal to human studies revisited

  2007cited by this paper
• Effect of pore former on the properties of casted film prepared from blends of Eudragit NE 30 D and Eudragit L 30 D-55.

  2007cited by this paper
• Development of nitrendipine transdermal patches: in vitro and ex vivo characterization.

  2007cited by this paper
• Drugs acting as plasticizers in polymeric systems: a quantitative treatment.

  2006cited by this paper
• Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride

  2006cited by this paper
• Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.

  2006cited by this paper
• Design and evaluation of a water-soluble bioadhesive patch formulation for cutaneous delivery of 5-aminolevulinic acid to superficial neoplastic lesions.

  2006cited by this paper
• Analysis of surface properties of cellulose ethers and drug release from their matrix tablets.

  2006cited by this paper
• Skin permeation and stability studies of 5-aminolevulinic acid in a new gel and patch preparation.

  2005cited by this paper
• A comparison between povidone-ethylcellulose and povidone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeation.

  2005cited by this paper
• Preparation and evaluation of a chitosan salt-poloxamer 407 based matrix for buccal drug delivery.

  2005cited by this paper
• Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use.

  2005cited by this paper
• Characterization of cellulosic hot-melt extruded films containing lidocaine.

  2005cited by this paper
• Miscibility Behavior and Formation Mechanism of Stabilized Felodipine-Polyvinylpyrrolidone Amorphous Solid Dispersions

  2005cited by this paper
• Dose adjustment in renal impairment: Response from AHFS Drug Information

  2005cited by this paper
• Effective And Controlled Transdermal Delivery Of Metoprolol Tartarate

  2005cited by this paper
• In vitro release studies of chlorpheniramine maleate from gels prepared by different cellulose derivatives.

  2003cited by this paper
• Muscle Relaxants for Nonspecific Low Back Pain: A Systematic Review Within the Framework of the Cochrane Collaboration

  2003cited by this paper
• Monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: in vitro characterisation.

  2002cited by this paper
• Studies on indomethacin inserts prepared by water-soluble polymers. II. The relation between dissolution rate and swelling behaviour.

  2001cited by this paper
• Design, characterisation and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease.

  2000cited by this paper
• Delivery of nalbuphine and its prodrugs across skin by passive diffusion and iontophoresis.

  2000cited by this paper
• Pharmacokinetic profile of a new matrix-type transdermal delivery system: diclofenac diethyl ammonium patch.

  1999cited by this paper
• Role of dissolution studies in controlled release drug delivery systems

  1999cited by this paper
• Development and characterisation of a moisture-activated bioadhesive drug delivery system for percutaneous local anaesthesia

  1998cited by this paper
• Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration.

  1998cited by this paper
• Permeability studies of cellulose acetate free films for transdermal use: influence of plasticizers.

  1997cited by this paper
• Remington:the science and practice of pharmacy

  1995cited by this paper
• Correlations between dose, plasma concentrations, and antispastic action of tizanidine (Sirdalud).

  1994cited by this paper
• Permeability of progesterone and a synthetic progestin through methacrylic films

  1991cited by this paper
• [Matrices for controlled liberation by swelling of polymers. II: Preparation of drug delivery systems and analysis of liberation kinetics].

  1986cited by this paper
• Analysis of data on the medicament release from ointments.

  1962cited by this paper

• Nanocrystal-loaded dissolving microneedles: A novel transdermal strategy for long-acting tizanidine administration

  2025cites this paper
• Chitosan-based buccal mucoadhesive bilayer tablets enhance the bioavailability of Tizanidine hydrochloride by bypassing the first-pass metabolism

  2024cites this paper
• Recent Options and Techniques to Assess Improved Bioavailability: In Vitro and Ex Vivo Methods

  2023cites this paper
• Bile salt stabilized nanovesicles as a promising drug delivery technology: A general overview and future perspectives

  2022cites this paper
• Fabrication of Transdermal Matrix Patch of Lercanidipine Hydrochloride Using Natural Polymer and Essential Oil

  2022cites this paper
• Development of tizanidine loaded aspasomes as transdermal delivery system: ex-vivo and in-vivo evaluation

  2021cites this paper
• Fabrication of Tizanidine Loaded Patches Using Flaxseed Oil and Coriander Oil as a Penetration Enhancer for Transdermal Delivery

  2021cites this paper
• APPROACHES FOR THE DELIVERY OF SKELETAL MUSCLE RELAXANTS: A REVIEW

  2019cites this paper
• Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system

  2018cites this paper
• Evaluation of bilosomes as nanocarriers for transdermal delivery of tizanidine hydrochloride: in vitro and ex vivo optimization

  2018cites this paper
• Formulation And Evaluation Of The Prepared Floating Raft System Of Tizanidine HCL

  2017cites this paper
• Formulation and evaluation of repaglinide patches for transdermal drug delivery

  2017cites this paper
• Formulation and Evaluation of Nateglinide Patches for Transdermal Drug Delivery.

  2017cites this paper
• FORMULATION AND EVALUATION OF GLIMEPIRIDE PATCHES FOR TRANSDERMAL DRUG DELIVERY

  2016cites this paper
• Comparative Study of Matrix Transdermal patches of Metoprolol: In Vitro and In Vivo Characterization

  2015cites this paper